Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer

Lingyi Shi,1,* Hailun Zheng,1,* Wanle Hu,2 Bin Zhou,2 Xuanxuan Dai,3 Yi Zhang,3 Zhiguo Liu,1 Xiaoping Wu,1 Chengguang Zhao,1 Guang Liang1 1Chemical Biology Research Center, School of Pharmaceutical Sciences, 2Department of Coloproctology, The Second Affiliated Hospital and Yuying Children&rsquo...

Full description

Bibliographic Details
Main Authors: Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:OncoTargets and Therapy
Subjects:
STAT3
EGFR
Erlotinib
Niclosamide
Colon cancer
Online Access:https://www.dovepress.com/niclosamide-inhibition-of-stat3-synergizes-with-erlotinib-in-human-col-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/niclosamide-inhibition-of-stat3-synergizes-with-erlotinib-in-human-col-peer-reviewed-article-OTT

Similar Items